US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Timothy Ko

Recent news which mentions Timothy Ko

Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin
Tickers CYBE CYBN ENTBF
Tags Doug Drysdale Timothy Ko Asset Sales
From Benzinga
Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research
Tickers EHVVF ENTBF
Tags EHVVF General Benzinga
From Benzinga
Entheon Biomedical Corp. Strengthens Its Psychedelic-Assisted Protocols Through Acquisition Of Lobo Genetics
Tickers ENTBF
Tags Benzinga John Lem Timothy Ko
From Benzinga